Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Inflammatory arthritis
What is your approach to management of inflammatory arthritis in the setting of multisystem inflammatory syndrome in adults (MIS-A) after COVID?
Related Questions
What is the difference between Multisystem Inflammatory Syndrome in Adults (MIS-A) and MAS/HLH?
When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?
How would you manage monoarticular rice body synovitis in the setting of negative infectious work up?
Do you recommend routine use of Evusheld for pre-exposure prophylaxis for patients on immunosuppression?
Do you use tocilizumab for the treatment of severe COVID-19 in patients who are on other biologics for rheumatic diseases, such as rituximab?
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Is rituximab for refractory ITP contraindicated in the setting of an active COVID infection, particularly in a patient with asymptomatic COVID?
How do you think about biologic use in patients with underlying HIV infection?
How are you counseling immunosuppressed patients regarding monkeypox vaccination?
What is your approach to management of post Covid inflammatory arthritis?
